Sumitomo Pharma Co., Ltd.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
Compared with Healthcare companies in Japan.
P/E ratio
8.2Investors pay 8.2 for every 1 of Sumitomo Pharma Co., Ltd.'s yearly profit, lower than 97% of Healthcare companies in Japan.
P/B ratio
2.14The share price is 2.14 times Sumitomo Pharma Co., Ltd.'s book value per share, higher than 75% of Healthcare companies in Japan.
Market cap
¥873.0 BThe total market value of all of Sumitomo Pharma Co., Ltd.'s shares at today's price (share price × number of shares), larger than 80% of Healthcare companies in Japan. PosiCap size class: Meso Cap.
Return on equity (ROE)
38.5%Sumitomo Pharma Co., Ltd. earned 38.5% on its shareholders' money over the last year, higher than almost all Healthcare companies in Japan.
Dividend yield
NoneSumitomo Pharma Co., Ltd. does not currently pay a dividend.
Questions
What is Sumitomo Pharma Co., Ltd.'s P/E ratio?
Investors pay 8.2 for every 1 of Sumitomo Pharma Co., Ltd.'s yearly profit, lower than 97% of Healthcare companies in Japan.
What is Sumitomo Pharma Co., Ltd.'s return on equity?
Sumitomo Pharma Co., Ltd. earned 38.5% on its shareholders' money over the last year, higher than almost all Healthcare companies in Japan.
Does Sumitomo Pharma Co., Ltd. pay a dividend?
No. Sumitomo Pharma Co., Ltd. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.